StockWatch
·

Vivos Therapeutics, Inc.

Ticker: 1716166

Board Meeting in 10 days
values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-10.60-2.176.2514.68Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26

Margin Trend

percentage
OPM %NPM %
-110.45-80.26-50.07-19.87Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26
PeriodQ3 FY26Q2 FY26Q1 FY26Q3 FY25Q2 FY25Q1 FY25Q3 FY24Q2 FY24
INCOME
Revenue6.41+24.5%5.15+0.2%5.14-24.2%6.78+77.5%3.82+26.5%3.02-21.8%3.86-4.7%4.05
Total Income6.41+24.5%5.15+0.2%5.14-24.2%6.78+77.5%3.82+26.5%3.02-21.8%3.86-4.7%4.05
EXPENSES
Expenditure10.31+3.3%9.98-15.1%11.76+2.1%11.52+32.6%8.69+25.4%6.93+6.5%6.51+8.7%5.99
PROFIT
PBT-1.97+64.3%-5.52+28.8%-7.75-43.5%-5.40-7.8%-5.01-29.8%-3.86-47.3%-2.62-35.8%-1.93
Net Profit-1.95+64.4%-5.48+28.6%-7.68-42.2%-5.40-7.8%-5.01-29.8%-3.86-47.3%-2.62-35.8%-1.93
KEY METRICS
OPM %-60.74%+32.89pp-93.64%+6.36pp-100.00%-30.21pp-69.79%+30.21pp-100.00%-100.00%-31.48pp-68.52%-20.77pp-47.76%
NPM %-30.32%+69.67pp-100.00%-100.00%-20.39pp-79.61%+20.39pp-100.00%-100.00%-32.23pp-67.77%-20.17pp-47.61%
EPS-0.07+77.4%-0.31+40.4%-0.52-6.1%-0.49+10.9%-0.55-22.2%-0.45-12.5%-0.40+33.3%-0.60